Annick Verhee

Journal Article
A1
open access

Modeling of glucocorticoid resistance in multiple myeloma reveals mechanisms and markers of glucocorticoid resistance

Bert Luyckx (UGent) , Mélanie Derollez, Eleni Staessens (UGent) , Annick Verhee (UGent) , Daria Fijalkowska (UGent) , Pieter Van Vlierberghe (UGent) , Steven Goossens (UGent) , Dorien Clarisse (UGent) and Karolien De Bosscher (UGent)

(2025) BIOMEDICINE & PHARMACOTHERAPY. 192.

Add to list

Journal Article
A1
open access

CCR1 inhibition sensitizes multiple myeloma cells to glucocorticoid therapy

Bert Luyckx (UGent) , Maaike Van Trimpont (UGent) , Fien Declerck, Eleni Staessens (UGent) , Annick Verhee (UGent) , Sara T'Sas (UGent) , Sven Eyckerman (UGent) , Fritz Offner (UGent) , Pieter Van Vlierberghe (UGent) , Steven Goossens, et al.

(2025) PHARMACOLOGICAL RESEARCH. 215.

Add to list

Journal Article
A2
open access

Leveraging a self-cleaving peptide for tailored control in proximity labeling proteomics

Louis Delhaye (UGent) , Georgios Moschonas (UGent) , Daria Fijalkowska (UGent) , Annick Verhee (UGent) , Delphine De Sutter (UGent) , Tessa Van de Steene (UGent) , Margaux De Meyer (UGent) , Hanna Grzesik (UGent) , Laura Van Moortel (UGent) , Karolien De Bosscher (UGent) , et al.

(2024) CELL REPORTS METHODS. 4(7).

Add to list

Journal Article
A1
open access

Selective modulation of the human glucocorticoid receptor compromises GR chromatin occupancy and recruitment of p300/CBP and the Mediator complex

Laura Van Moortel (UGent) , Annick Verhee (UGent) , Jonathan Thommis (UGent) , René Houtman, Diana Melchers, Louis Delhaye (UGent) , Chloé Van Leene (UGent) , Madeleine Hellemans (UGent) , Kris Gevaert (UGent) , Sven Eyckerman (UGent) , et al.

(2024) MOLECULAR & CELLULAR PROTEOMICS. 23(3).

Add to list

Journal Article
A1
open access

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Sandra Van Lint (UGent) , Alexander Van Parys (UGent) , Bram Van Den Eeckhout (UGent) , Niels Vandamme (UGent) , Stephane Plaisance, Annick Verhee (UGent) , Dominiek Catteeuw (UGent) , Elke Rogge (UGent) , Jennifer De Geest (UGent) , Nele Vanderroost (UGent) , et al.

(2023) MOLECULAR CANCER. 22(1).

Add to list

Journal Article
A1
open access

Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Elke Rogge, Annick Verhee (UGent) , Bram Van Den Eeckhout (UGent) , Shengru Pang, Marco Prinz, Niko Kley, Gilles Uze and Jan Tavernier (UGent)

(2021) SCIENTIFIC REPORTS. 11(1).

Add to list

Journal Article
A1
open access

Rapid and effective generation of nanobody based CARs using PCR and Gibson Assembly

Stijn De Munter (UGent) , Alexander Van Parys (UGent) , Layla Bral, Joline Ingels (UGent) , Glenn Goetgeluk (UGent) , Sarah Bonte (UGent) , Melissa Pille (UGent) , Lore Billiet (UGent) , Karin Weening (UGent) , Annick Verhee (UGent) , et al.

(2020) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 21(3).

Add to list

Journal Article
A1
open access

Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies

Leander Huyghe (UGent) , Alexander Van Parys (UGent) , Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Stijn De Munter (UGent) , Jennyfer Bultinck (UGent) , Lennart Zabeau (UGent) , Jeroen Hostens, An Goethals, Nele Vanderroost (UGent) , et al.

(2020) EMBO MOLECULAR MEDICINE. 12(2).

Add to list

Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Dominiek Catteeuw (UGent) , Shengru Pang, Franciane Paul, Elke Rogge (UGent) , Annick Verhee (UGent) , Marco Prinz, Niko Kley, Gilles Uzé, et al.

(2019) JOURNAL OF AUTOIMMUNITY. 97. p.70-76

Add to list

Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Franciane Paul, Genevieve Garcin, Stefaan De Koker (UGent) , Alexander Van Parys (UGent) , Thomas Wüest (UGent) , Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yan Bordat, et al.

(2018) CANCER RESEARCH. 78(2). p.463-474

Academic Bibliography

Annick Verhee

Modeling of glucocorticoid resistance in multiple myeloma reveals mechanisms and markers of glucocorticoid resistance

CCR1 inhibition sensitizes multiple myeloma cells to glucocorticoid therapy

Leveraging a self-cleaving peptide for tailored control in proximity labeling proteomics

Selective modulation of the human glucocorticoid receptor compromises GR chromatin occupancy and recruitment of p300/CBP and the Mediator complex

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE

Rapid and effective generation of nanobody based CARs using PCR and Gibson Assembly

Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies

Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice

Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

Contents

Support

Contact